While some studies have ascribed an anti-tumor role for IL-17-producing γδ T cells like when they act in concert with immunogenic cell death-inducing chemotherapeutic drugs [27], in a range of other settings a pro-tumor role has been proposed [1,2,28]. Here, IL17A is linked to neoplasm.